Cibc World Markets Corp Tarsus Pharmaceuticals, Inc. Transaction History

Cibc World Markets Corp

  • $14.8 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$41.29 - $56.94 $341,055 - $470,324
8,260 New
8,260 $424,000
Q1 2024

May 13, 2024
BUY
$19.61 - $39.22 $2.94 Million - $5.88 Million
150,000 New
150,000 $5.45 Million
Q2 2023

Aug 04, 2023
BUY
$11.57 - $19.63 $578,500 - $981,500
50,000 New
50,000 $903,000

Others Institutions Holding TARS

# of Institutions
218
Shares Held
46.9M
Call Options Held
7.8K
Put Options Held
0
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.85B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email